ReviewCancer management and research2022

Role of Nivolumab in the Management of First-Line Unresectable Advanced or Recurrent Gastric Cancer in Combination with Chemotherapy: Lessons from the Japanese Experience.

Yohei Kubota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.